Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 of  45,273 نتائج ل ""Vaccines""

فلترة النتائج

Subject : colorado Subject : covid-19 Subject : district of columbia Subject : docencia Subject : foreign countries Subject : higher education Subject : lc8-6691 فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cross-Reactive Antibody Responses to Coronaviruses Elicited by SARS-CoV-2 Infection or Vaccination.

  • Authors : Lee RSH; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Cheng SMS

Subjects: Cross Reactions*/Cross Reactions*/Cross Reactions*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13309.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.

  • Authors : Wüsthoff LEC; Unit for Clinical Research on Addictions, Oslo University Hospital, PO Box 4959 Nydalen, Oslo, 0424, Norway. .; Norwegian Centre for Addiction Reasearch, Institute of Clinical Medicine, University of Oslo, PO Box 1039 Blindern, Oslo, 0315, Norway. .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Harm reduction journal [Harm Reduct J] 2024 Jun 19; Vol. 21 (1), pp. 120. Date of Electronic Publication: 2024 Jun 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Long-lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID-19 vaccination.

  • Authors : Boros LG; Sub-Molecular Medical Sciences Deutenomics Core, Vrije University Amsterdam, Amsterdam, The Netherlands.; Kyriakopoulos AM

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Jun; Vol. 12 (3), pp. e1218.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Enhancing vaccination uptake through community engagement: evidence from China.

  • Authors : Guan H; Center for Experimental Economics in Education, Shaanxi Normal University, Xian, 710119, China.; Zhang L

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: Scientific reports [Sci Rep] 2024 May 13; Vol. 14 (1), pp. 10845. Date of Electronic Publication: 2024 May 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.

  • Authors : Iwata S; Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan.; Pollard AJ

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Scientific reports [Sci Rep] 2024 Apr 29; Vol. 14 (1), pp. 9830. Date of Electronic Publication: 2024 Apr 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial.

  • Authors : Huang T; Hunan Provincial Center for Disease Control and Prevention, Changsha, 410005, China.; Hu Q

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Vaccines, Subunit*

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 19; Vol. 24 (1), pp. 413. Date of Electronic Publication: 2024 Apr 19.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.

Subjects: Influenza, Human* ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/genetics ; COVID-19*

  • Source: Virology journal [Virol J] 2024 Apr 09; Vol. 21 (1), pp. 82. Date of Electronic Publication: 2024 Apr 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Antibody Response Before and After the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients.

  • Authors : Movahedi M; Division of Allergy and Clinical Immunology, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran. .; Movahedi M

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunization, Secondary*

  • Source: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2024 Apr 07; Vol. 23 (2), pp. 158-167. Date of Electronic Publication: 2024 Apr 07.Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101146178 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.

  • Authors : Lobaina Y; Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Lengshuitan District, Yongzhou 425000, China.; R&D Department, Yongzhou Zhong Gu Biotechnology Co., Ltd., Yangjiaqiao Street, Lengshuitan District, Yongzhou 425000, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Animals SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Mar 08; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.

  • Authors : Clever S; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.; Limpinsel L

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; gamma-Globulins*

  • Source: Viruses [Viruses] 2024 Mar 08; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 of  45,273 نتائج ل ""Vaccines""